[Federal Register: June 5, 2003 (Volume 68, Number 108)]
[Notices]               
[Page 33684]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05jn03-51]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Taqman 
Internal Positive Control

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Provisional Patent 
Application No. 60/361,455 entitled ``Taqman Internal Positive 
Control,'' filed March 4, 2002. Foreign rights are also available (PCT/
US03/06347). The United States Government, as represented by the 
Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The prevent invention generally relates to 
probes comprising a reporter molecule and a quencher molecule for use 
in nucleic acid assays. In particular, the present invention relates to 
a universal internal positive control that may be used in polymerase 
chain reaction (PCR) based assays.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 03-14155 Filed 6-4-03; 8:45 am]

BILLING CODE 3710-08-M